Impact of Treatment Induced Premature Menopause on Quality of Life

Menopause, Premature Clinical Trial

Official title:

Impact of Treatment Induced Premature Menopause on Quality of Life Following Blood and Marrow Transplantation

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT00185718
• Other study ID #: BMT160
• Secondary ID: 79700BMT16013644
• Status: Completed
• Phase: N/A
• First received: September 12, 2005
• Last updated: December 12, 2012
• Start date: November 2003
• Est. completion date: September 2010

Study information

• Verified date: December 2012
• Source: Stanford University
• Contact: n/a
• Is FDA regulated: No
• Health authority: United States: Food and Drug AdministrationUnited States: Institutional Review Board
• Study type: Observational

Clinical Trial Summary

To understand the impact of treatment induced menopause on quality of life and sexuality following blood and marrow transplantation.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 97
• Est. completion date: September 2010
• Est. primary completion date: September 2010
• Accepts healthy volunteers: No
• Gender: Female
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• premenopausal

• sexually active women

• able to read and write English

Exclusion Criteria:

• postmenopausal females

Study Design

Time Perspective: Prospective

Related Conditions & MeSH terms

• Menopause, Premature
• Premature Birth

Locations

Country	Name	City	State
United States	Stanford University School of Medicine	Stanford	California

Sponsors (1)

Lead Sponsor	Collaborator
Stanford University

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Quality of life	To describe the impact of premature menopause on sexuality and quality of life.	1 year	No
Primary	Sexuality	To describe the impact of premature menopause on sexuality and quality of life.	1 year	No